Abstract
Background: Thyroid dysfunction is one of the most important side effects of lithium carbonate. Silymarin is a flavonolignan extracted from the milk thistle Silybum marianum (L.), which has remarkable antioxidant and therapeutic properties. This clinical trial study aimed to evaluate the effect of silymarin on thyroid function and serum antioxidant status in patients with lithium-treated bipolar disorder.
Methods: Bipolar patients with a depression episode and a history of at least six months of lithium use were randomly divided into placebo-control (n=18) and intervention (n=19) groups. In addition to standard medication, patients in the intervention and control groups received silymarin (140 mg) and placebo tablets daily for ten weeks, respectively. Finally, thyroid function and serum antioxidant status were evaluated along with clinical signs at the beginning and the tenth week.
Results: Following the administration of silymarin, a significant increase was observed in total antioxidant capacity (p = 0.004) and total thiol molecules (p = 0.005) levels in serum compared to the placebo group. Although silymarin had no significant effect on serum triiodothyronine (T3) and lithium levels, it could significantly improve the secretory status of thyroid-stimulating hormone (TSH; p = 0.002) and Thyroxine (T4; p = 0.02) hormones in comparison to the placebo group.
Conclusion: The current study showed that silymarin might be effective for thyroid function in lithium- treated bipolar patients by improving body’s antioxidant status.
Graphical Abstract
[1]
Tondo L. Vلzquez G, Baldessarini R. Depression and mania in bipolar disorder. Curr Neuropharmacol 2017; 15(3): 353-8.
[http://dx.doi.org/10.2174/1570159X14666160606210811] [PMID: 28503106]
[http://dx.doi.org/10.2174/1570159X14666160606210811] [PMID: 28503106]
[2]
Sampogna G, Janiri D, Albert U, et al. Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper. Expert Rev Neurother 2022; 22(11-12): 923-34.
[http://dx.doi.org/10.1080/14737175.2022.2161895] [PMID: 36562412]
[http://dx.doi.org/10.1080/14737175.2022.2161895] [PMID: 36562412]
[3]
Joseph B, Nunez NA, Pazdernik V, et al. Long-term lithium therapy and thyroid disorders in bipolar disorder: A historical cohort study. Brain Sci 2023; 13(1): 133.
[http://dx.doi.org/10.3390/brainsci13010133] [PMID: 36672114]
[http://dx.doi.org/10.3390/brainsci13010133] [PMID: 36672114]
[4]
Ferensztajn-Rochowiak E, Rybakowski JK. Long-term lithium therapy: Side effects and interactions. Pharmaceuticals (Basel) 2023; 16(1): 74.
[http://dx.doi.org/10.3390/ph16010074] [PMID: 36678571]
[http://dx.doi.org/10.3390/ph16010074] [PMID: 36678571]
[5]
Mohammadi H, Saghaian S. Factors affecting consumption of different forms of medicinal plants: The case of licorice. Agriculture 2022; 12(9): 1453.
[http://dx.doi.org/10.3390/agriculture12091453]
[http://dx.doi.org/10.3390/agriculture12091453]
[6]
El-Saadony MT, Zabermawi NM, Zabermawi NM, et al. Nutritional aspects and health benefits of bioactive plant compounds against infectious diseases: A review. Food Rev Int 2023; 39(4): 2138-60.
[http://dx.doi.org/10.1080/87559129.2021.1944183]
[http://dx.doi.org/10.1080/87559129.2021.1944183]
[7]
Ebrahimpour koujan S, Gargari BP, Mobasseri M, Valizadeh H, Asghari-Jafarabadi M. Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: A randomized, triple-blind, placebo-controlled clinical trial. Phytomedicine 2015; 22(2): 290-6.
[http://dx.doi.org/10.1016/j.phymed.2014.12.010] [PMID: 25765835]
[http://dx.doi.org/10.1016/j.phymed.2014.12.010] [PMID: 25765835]
[8]
Soleimani V, Delghandi PS, Moallem SA, Karimi G. Safety and toxicity of silymarin, the major constituent of milk thistle extract: An updated review. Phytother Res 2019; 33(6): 1627-38.
[http://dx.doi.org/10.1002/ptr.6361] [PMID: 31069872]
[http://dx.doi.org/10.1002/ptr.6361] [PMID: 31069872]
[9]
Boojar MM, Boojar MM, Golmohammad S. Overview of Silibinin anti-tumor effects. J Herb Med 2020; 23: 100375.
[http://dx.doi.org/10.1016/j.hermed.2020.100375]
[http://dx.doi.org/10.1016/j.hermed.2020.100375]
[10]
Mohammadi M, Atashpour S, Pourkhalil N, et al. Comparative improvement in function of isolated rat Langerhans islets by various phosphodiesterase 3, 4 and 5 inhibitors. Asian J Anim Vet Adv 2011; 6(12): 1233-40.
[http://dx.doi.org/10.3923/ajava.2011.1233.1240]
[http://dx.doi.org/10.3923/ajava.2011.1233.1240]
[11]
Onaolapo AY, Sulaiman H, Olofinnade AT, Onaolapo OJ. Antidepressant-like potential of silymarin and silymarin-sertraline combination in mice: Highlighting effects on behaviour, oxidative stress, and neuroinflammation. World J Pharmacol 2022; 11(3): 27-47.
[http://dx.doi.org/10.5497/wjp.v11.i3.27]
[http://dx.doi.org/10.5497/wjp.v11.i3.27]
[12]
Lv Q, Guo Y, Zhu M, et al. Predicting individual responses to lithium with oxidative stress markers in drug-free bipolar disorder. World J Biol Psychiatry 2019; 20(10): 778-89.
[http://dx.doi.org/10.1080/15622975.2019.1663929] [PMID: 31595816]
[http://dx.doi.org/10.1080/15622975.2019.1663929] [PMID: 31595816]
[13]
Niu Z, Wu X, Zhu Y, et al. Early Diagnosis of bipolar disorder coming soon: application of an oxidative stress injury biomarker (BIOS) model. Neurosci Bull 2022; 38(9): 979-91.
[http://dx.doi.org/10.1007/s12264-022-00871-4] [PMID: 35590012]
[http://dx.doi.org/10.1007/s12264-022-00871-4] [PMID: 35590012]
[14]
Jiménez-Fernلndez S, Gurpegui M, Garrote-Rojas D, Gutiérrez-Rojas L, Carretero MD, Correll CU. Oxidative stress parameters and antioxidants in patients with bipolar disorder: Results from a meta‐analysis comparing patients, including stratification by polarity and euthymic status, with healthy controls. Bipolar Disord 2021; 23(2): 117-29.
[http://dx.doi.org/10.1111/bdi.12980] [PMID: 32780547]
[http://dx.doi.org/10.1111/bdi.12980] [PMID: 32780547]
[15]
Hamidi R, Fekrizadeh Z, Azadbakht M, et al. Validity and reliability Beck Depression Inventory-II among the Iranian elderly population. JSUMS 2015; 22(1): 189-98.
[16]
Kraszewska A, Ziemnicka K. Jończyk-Potoczna K, Sowiński J, Rybakowski JK. Thyroid structure and function in long‐term lithium‐treated and lithium‐naïve bipolar patients. Hum Psychopharmacol 2019; 34(4): e2708.
[http://dx.doi.org/10.1002/hup.2708] [PMID: 31297898]
[http://dx.doi.org/10.1002/hup.2708] [PMID: 31297898]
[17]
Duce HL, Duff CJ, Zaidi S, Parfitt C, Heald AH, Fryer AA. Evaluation of thyroid function monitoring in people treated with lithium: Advice based on real‐world data. Bipolar Disord 2023; 00: bdi.13298.
[http://dx.doi.org/10.1111/bdi.13298] [PMID: 36645255]
[http://dx.doi.org/10.1111/bdi.13298] [PMID: 36645255]
[18]
Czarnywojtek A, Zgorzalewicz-Stachowiak M, Czarnocka B, et al. Effect of lithium carbonate on the function of the thyroid gland: Mechanism of action and clinical implications. J Physiol Pharmacol 2020; 71(2): 191-9.
[http://dx.doi.org/10.26402/jpp.2020.2.03] [PMID: 32633237]
[http://dx.doi.org/10.26402/jpp.2020.2.03] [PMID: 32633237]
[19]
Mazzilli R, Medenica S, Di Tommaso AM, et al. The role of thyroid function in female and male infertility: A narrative review. J Endocrinol Invest 2022; 46(1): 15-26.
[http://dx.doi.org/10.1007/s40618-022-01883-7] [PMID: 35945393]
[http://dx.doi.org/10.1007/s40618-022-01883-7] [PMID: 35945393]
[20]
Toplan S, Dariyerli N, Ozdemir S, Ozcelik D, Zengin EU, Akyolcu MC. Lithium-induced hypothyroidism: Oxidative stress and osmotic fragility status in rats. Biol Trace Elem Res 2013; 152(3): 373-8.
[http://dx.doi.org/10.1007/s12011-013-9629-4] [PMID: 23408263]
[http://dx.doi.org/10.1007/s12011-013-9629-4] [PMID: 23408263]
[21]
Ghiasian M, Nafisi H, Ranjbar A, Mohammadi Y, Ataei S. Antioxidative effects of silymarin on the reduction of liver complications of fingolimod in patients with relapsing–remitting multiple sclerosis: A clinical trial study. J Biochem Mol Toxicol 2021; 35(8): e22800.
[http://dx.doi.org/10.1002/jbt.22800] [PMID: 33934443]
[http://dx.doi.org/10.1002/jbt.22800] [PMID: 33934443]
[22]
Abd El-Twab SM, Abdul-Hamid M. Curcumin mitigates lithium-induced thyroid dysfunction by modulating antioxidant status, apoptosis and inflammatory cytokines. J Basic Appl Zool 2016; 76: 7-19.
[http://dx.doi.org/10.1016/j.jobaz.2016.10.001]
[http://dx.doi.org/10.1016/j.jobaz.2016.10.001]
[23]
Yardım A, Kucukler S, Özdemir S, et al. Silymarin alleviates docetaxel-induced central and peripheral neurotoxicity by reducing oxidative stress, inflammation and apoptosis in rats. Gene 2021; 769: 145239.
[http://dx.doi.org/10.1016/j.gene.2020.145239] [PMID: 33069805]
[http://dx.doi.org/10.1016/j.gene.2020.145239] [PMID: 33069805]
[24]
Roozbeh J, Shahriyari B, Akmali M, et al. Comparative effects of silymarin and vitamin E supplementation on oxidative stress markers, and hemoglobin levels among patients on hemodialysis. Ren Fail 2011; 33(2): 118-23.
[http://dx.doi.org/10.3109/0886022X.2010.541579] [PMID: 21332331]
[http://dx.doi.org/10.3109/0886022X.2010.541579] [PMID: 21332331]
[25]
Lucena MI, Andrade RJ, Cruz JP, Rodriguez-Mendizabal M, Blanco E, Cuesta FS. Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. Int J Clin Pharmacol Ther 2002; 40(1): 2-8.
[http://dx.doi.org/10.5414/CPP40002] [PMID: 11841050]
[http://dx.doi.org/10.5414/CPP40002] [PMID: 11841050]
[26]
Mirzaei E, Sabetian G, Masjedi M, et al. The effect of silymarin on liver enzymes and antioxidant status in trauma patients in the intensive care unit: A randomized double blinded placebo-controlled clinical trial. Clin Exp Hepatol 2021; 7(2): 149-55.
[http://dx.doi.org/10.5114/ceh.2021.107067] [PMID: 34295981]
[http://dx.doi.org/10.5114/ceh.2021.107067] [PMID: 34295981]
